EUVIMEDEUVIMED entdecken
Vergleichsstudie

Transarterial Chemoembolization Alone Versus Combined With Radiation Therapy as First-Line Therapy for Early-Stage Single Hepatocellular Carcinoma

Hye In Lee, Jinhong Jung, So Yeon Kim, Jonggi Choi, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Sang Min Yoon

International Journal of Radiation Oncology*Biology*Physics · 2025

DOI: 10.1016/j.ijrobp.2025.11.062 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2025. Verfasst von Hye In Lee und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Asan Liver Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Chemoembolization, Therapeutic. Die Arbeit nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: This study aimed to evaluate survival outcomes of transarterial chemoembolization (TACE) alone versus TACE plus radiation therapy (RT) as first-line treatment in patients with single hepatocellular carcinoma (HCC) within Barcelona Clinic Liver Cancer (BCLC) stage 0-A. METHODS AND MATERIALS: We retrospectively analyzed 1243 treatment-naïve patients with BCLC stage 0-A single HCC who received TACE alone (n = 986) or TACE plus RT (n = 257) between January 2008 and December 2018. Propensity score matching and subgroup analyses were performed to compare overall survival (OS) and progression-free survival (PFS) between the treatment groups, and to identify patient subsets most likely to benefit from combined therapy. RESULTS: The median age was 61 years (IQR, 55-69); 38% of the patients had BCLC stage 0 disease, whereas 62% had stage A disease. Baseline characteristics were comparable between groups, except for a higher rate of noncomplete response to TACE in the TACE plus RT group. At a median follow-up of 54.7 months, TACE plus RT demonstrated significantly higher 5-year OS (76.4% vs 62.5%; P 4 cm), alpha-fetoprotein levels (> 100 ng/mL), and TACE response (noncomplete response). Incorporating these factors, the TACE-RT stratification model categorized patients into distinct groups with differential treatment effects: groups B (1 factor) and C (2-3 factors) derived significant survival benefits from combined therapy, whereas group A (no factors) showed no differences. Early RT integration yielded superior OS and PFS compared with delayed integration. CONCLUSIONS: TACE combined with RT as first-line treatment was associated with improved OS and PFS compared with TACE alone in selected patients with BCLC stage 0-A single HCC. Our TACE-RT stratification model may help identify appropriate candidates for combined therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsChemoembolization, TherapeuticHumansRetrospective StudiesMiddle AgedFemaleMaleCombined Modality TherapyAgedNeoplasm StagingPropensity ScoreTreatment OutcomeProgression-Free Survival

Autor:innen und Institutionen

  • Department of Radiation Oncology, Asan Liver Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Department of Radiation Oncology, Asan Liver Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea. Electronic address: jung.jinhong@amc.seoul.kr.
  • Department of Radiology, Asan Liver Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Department of Gastroenterology, Asan Liver Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.

Zitieren

APA

Lee, H. I., Jung, J., Kim, S. Y., Choi, J., Lee, D., Shim, J. H., Kim, K. M., Lim, Y. S., Lee, H. C., & Yoon, S. M. (2025). Transarterial Chemoembolization Alone Versus Combined With Radiation Therapy as First-Line Therapy for Early-Stage Single Hepatocellular Carcinoma. International Journal of Radiation Oncology*Biology*Physics. https://doi.org/10.1016/j.ijrobp.2025.11.062

Vancouver

Lee HI, Jung J, Kim SY, Choi J, Lee D, Shim JH, et al. Transarterial Chemoembolization Alone Versus Combined With Radiation Therapy as First-Line Therapy for Early-Stage Single Hepatocellular Carcinoma. International Journal of Radiation Oncology*Biology*Physics. 2025. doi:10.1016/j.ijrobp.2025.11.062

BibTeX
@article{Lee2025,
  author = {Lee, Hye In and Jung, Jinhong and Kim, So Yeon and Choi, Jonggi and Lee, Danbi and Shim, Ju Hyun and Kim, Kang Mo and Lim, Young-Suk and Lee, Han Chu and Yoon, Sang Min},
  title = {Transarterial Chemoembolization Alone Versus Combined With Radiation Therapy as First-Line Therapy for Early-Stage Single Hepatocellular Carcinoma},
  journal = {International Journal of Radiation Oncology*Biology*Physics},
  year = {2025},
  doi = {10.1016/j.ijrobp.2025.11.062}
}
Kostenlos starten →